Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep

Josh D. Boone; Udeni B. Balasuriya; Kemal Karaca; Jean Christophe Audonnet; Jiansheng Yao; Ling He; Robert Nordgren; Federica Monaco; Giovanni Savini; Ian Gardner; Nigel J Maclachlan

doi:10.1016/j.vaccine.2006.08.025

Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep

Josh D. Boone, Udeni B. Balasuriya, Kemal Karaca, Jean Christophe Audonnet, Jiansheng Yao, Ling He, Robert Nordgren, Federica Monaco, Giovanni Savini, Ian Gardner, Nigel J Maclachlan

School of Veterinary Medicine

Research output: Contribution to journal › Article › peer-review

79 Scopus citations

Abstract

We describe the development and preliminary characterization of a recombinant canarypox virus vectored vaccine for protective immunization of ruminants against bluetongue virus (BTV) infection. Sheep (n = 6) immunized with recombinant canarypox virus vector (BTV-CP) co-expressing synthetic genes encoding the two outer capsid proteins (VP2 and VP5) of BTV serotype 17 (BTV-17) developed high titers (40-160) of virus-specific neutralizing antibodies and were resistant to challenge with a field strain of BTV-17. In contrast, sheep (n = 5) immunized with a commercial recombinant canarypox virus vector expressing the E and preM genes of West Nile virus were seronegative to BTV and developed pyrexia, lymphopenia, and extended, high-titered viremias following challenge exposure to the field strain of BTV-17. These data confirm that the BTV-CP vaccine may be useful for the protective immunization of ruminants against bluetongue, and it may avoid the problems inherent to live-attenuated (LA) BTV vaccines.

Original language	English (US)
Pages (from-to)	672-678
Number of pages	7
Journal	Vaccine
Volume	25
Issue number	4
DOIs	https://doi.org/10.1016/j.vaccine.2006.08.025
State	Published - Jan 8 2007

Keywords

Bluetongue
Canarypox virus
Sheep
Vaccine

ASJC Scopus subject areas

Immunology
Microbiology
Virology
Infectious Diseases
Public Health, Environmental and Occupational Health
veterinary(all)

Access to Document

10.1016/j.vaccine.2006.08.025

Fingerprint Dive into the research topics of 'Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep'. Together they form a unique fingerprint.

Cite this

Boone, J. D., Balasuriya, U. B., Karaca, K., Audonnet, J. C., Yao, J., He, L., Nordgren, R., Monaco, F., Savini, G., Gardner, I., & Maclachlan, N. J. (2007). Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine, 25(4), 672-678. https://doi.org/10.1016/j.vaccine.2006.08.025

Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. / Boone, Josh D.; Balasuriya, Udeni B.; Karaca, Kemal; Audonnet, Jean Christophe; Yao, Jiansheng; He, Ling; Nordgren, Robert; Monaco, Federica; Savini, Giovanni; Gardner, Ian ; Maclachlan, Nigel J.

In: Vaccine, Vol. 25, No. 4, 08.01.2007, p. 672-678.

Research output: Contribution to journal › Article › peer-review

Boone, JD, Balasuriya, UB, Karaca, K, Audonnet, JC, Yao, J, He, L, Nordgren, R, Monaco, F, Savini, G, Gardner, I & Maclachlan, NJ 2007, 'Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep', Vaccine, vol. 25, no. 4, pp. 672-678. https://doi.org/10.1016/j.vaccine.2006.08.025

Boone, Josh D. ; Balasuriya, Udeni B. ; Karaca, Kemal ; Audonnet, Jean Christophe ; Yao, Jiansheng ; He, Ling ; Nordgren, Robert ; Monaco, Federica ; Savini, Giovanni ; Gardner, Ian ; Maclachlan, Nigel J. / Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. In: Vaccine. 2007 ; Vol. 25, No. 4. pp. 672-678.

@article{9217c55da856410c9a57ac255d17283e,

title = "Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep",

abstract = "We describe the development and preliminary characterization of a recombinant canarypox virus vectored vaccine for protective immunization of ruminants against bluetongue virus (BTV) infection. Sheep (n = 6) immunized with recombinant canarypox virus vector (BTV-CP) co-expressing synthetic genes encoding the two outer capsid proteins (VP2 and VP5) of BTV serotype 17 (BTV-17) developed high titers (40-160) of virus-specific neutralizing antibodies and were resistant to challenge with a field strain of BTV-17. In contrast, sheep (n = 5) immunized with a commercial recombinant canarypox virus vector expressing the E and preM genes of West Nile virus were seronegative to BTV and developed pyrexia, lymphopenia, and extended, high-titered viremias following challenge exposure to the field strain of BTV-17. These data confirm that the BTV-CP vaccine may be useful for the protective immunization of ruminants against bluetongue, and it may avoid the problems inherent to live-attenuated (LA) BTV vaccines.",

keywords = "Bluetongue, Canarypox virus, Sheep, Vaccine",

author = "Boone, {Josh D.} and Balasuriya, {Udeni B.} and Kemal Karaca and Audonnet, {Jean Christophe} and Jiansheng Yao and Ling He and Robert Nordgren and Federica Monaco and Giovanni Savini and Ian Gardner and Maclachlan, {Nigel J}",

year = "2007",

month = jan,

day = "8",

doi = "10.1016/j.vaccine.2006.08.025",

language = "English (US)",

volume = "25",

pages = "672--678",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "4",

}

TY - JOUR

T1 - Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep

AU - Boone, Josh D.

AU - Balasuriya, Udeni B.

AU - Karaca, Kemal

AU - Audonnet, Jean Christophe

AU - Yao, Jiansheng

AU - He, Ling

AU - Nordgren, Robert

AU - Monaco, Federica

AU - Savini, Giovanni

AU - Gardner, Ian

AU - Maclachlan, Nigel J

PY - 2007/1/8

Y1 - 2007/1/8

N2 - We describe the development and preliminary characterization of a recombinant canarypox virus vectored vaccine for protective immunization of ruminants against bluetongue virus (BTV) infection. Sheep (n = 6) immunized with recombinant canarypox virus vector (BTV-CP) co-expressing synthetic genes encoding the two outer capsid proteins (VP2 and VP5) of BTV serotype 17 (BTV-17) developed high titers (40-160) of virus-specific neutralizing antibodies and were resistant to challenge with a field strain of BTV-17. In contrast, sheep (n = 5) immunized with a commercial recombinant canarypox virus vector expressing the E and preM genes of West Nile virus were seronegative to BTV and developed pyrexia, lymphopenia, and extended, high-titered viremias following challenge exposure to the field strain of BTV-17. These data confirm that the BTV-CP vaccine may be useful for the protective immunization of ruminants against bluetongue, and it may avoid the problems inherent to live-attenuated (LA) BTV vaccines.

AB - We describe the development and preliminary characterization of a recombinant canarypox virus vectored vaccine for protective immunization of ruminants against bluetongue virus (BTV) infection. Sheep (n = 6) immunized with recombinant canarypox virus vector (BTV-CP) co-expressing synthetic genes encoding the two outer capsid proteins (VP2 and VP5) of BTV serotype 17 (BTV-17) developed high titers (40-160) of virus-specific neutralizing antibodies and were resistant to challenge with a field strain of BTV-17. In contrast, sheep (n = 5) immunized with a commercial recombinant canarypox virus vector expressing the E and preM genes of West Nile virus were seronegative to BTV and developed pyrexia, lymphopenia, and extended, high-titered viremias following challenge exposure to the field strain of BTV-17. These data confirm that the BTV-CP vaccine may be useful for the protective immunization of ruminants against bluetongue, and it may avoid the problems inherent to live-attenuated (LA) BTV vaccines.

KW - Bluetongue

KW - Canarypox virus

KW - Sheep

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=33845344012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845344012&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2006.08.025

DO - 10.1016/j.vaccine.2006.08.025

M3 - Article

C2 - 17059856

AN - SCOPUS:33845344012

VL - 25

SP - 672

EP - 678

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 4

ER -